Melinda K. Lacy - Concepedia

Author

Melinda K. Lacy

University of Kansas Medical Center ORCID

Also Known As

M K Lacy, Melinda K Lacy, Melinda K. Lacy, Melinda Lacy

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

University of Kansas Medical Center Hartford Hospital Hartford Financial Services (United States)University of Kansas The University of Kansas Health System

About

Melinda K. Lacy is an author at University of Kansas Medical Center specializing in medicine, drug resistance, and antibiotics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	319
2	Pharmacology	4	4	111
3	Health Sciences	3	3	86
4	Hospital Medicine	1	1	157
5	Microbiology	1	1	31

Melinda K. Lacy

Publications

666

Citations

H-Index

Page 1

	Year	Citations
Pharmacodynamic Comparisons of Levofloxacin, Ciprofloxacin, and Ampicillin against <i>Streptococcus pneumoniae</i> in an In Vitro Model of Infection Melinda K. Lacy, Wen Lu, Xiaowei Xu, Antimicrobial Agents and Chemotherapy	1999	217
Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia David P. Nicolau, JoCarol McNabb, Melinda K. Lacy, International Journal of Antimicrobial Agents Klebsiella PneumoniaePatient SafetyAcute CareSepsisNosocomial Pneumonia	2001	157
Nationwide Antibiogram Analysis Using NCCLS M39-A Guidelines Antonia Zapantis, Melinda K. Lacy, Rebecca T. Horvat, Journal of Clinical Microbiology	2005	74
Moxifloxacin: Clinical efficacy and safety Colleen M. Culley, Melinda K. Lacy, Neil E. Klutman, American Journal of Health-System Pharmacy Klebsiella PneumoniaePharmacotherapyAntimicrobial ChemotherapyDrug ResistanceAcute Sinusitis	2001	60
Effect of Duplicate Isolates of Methicillin-Susceptible and Methicillin-Resistant<i>Staphylococcus aureus</i>on Antibiogram Data Rebecca T. Horvat, Neil E. Klutman, Melinda K. Lacy, Journal of Clinical Microbiology	2003	33
Antibiograms: New NCCLS Guidelines, Development, and Clinical Application Melinda K. Lacy, Neil E. Klutman, Rebecca T. Horvat, Hospital Pharmacy Antimicrobial SusceptibilityAntimicrobial StewardshipAntibioticsDuplicate IsolatesHealthcare-associated Infection	2004	31
Pharmacokinetics and Pharmacodynamics of Continuous and Intermittent Ceftazidime during the Treatment of Nosocomial Pneumonia David P. Nicolau, JoCarol McNabb, Melinda K. Lacy, Clinical Drug Investigation MedicineKlebsiella PneumoniaeRespiratory InfectionNosocomial PneumoniaPharmacotherapy	1999	25
Telavancin Hospital-Acquired Pneumonia Trials: Impact of Gram-Negative Infections and Inadequate Gram-Negative Coverage on Clinical Efficacy and All-Cause Mortality Melinda K. Lacy, Martín E. Stryjewski, Whedy Wang, Clinical Infectious Diseases	2015	23
PHARMACOKINETICS OF CONTINUOUS AND INTERMITTENT CEFTAZIDIME IN INTENSIVE CARE UNIT PATIENTS WITH NOSOCOMIAL PNEUMONIA David P. Nicolau, Melinda K. Lacy, JoCarol McNabb, Infectious Diseases in Clinical Practice Antimicrobial StewardshipAntibioticsClinical TherapeuticAntimicrobial ResistanceSepsis	1999	20
Comparison of vancomycin pharmacodynamics (1 g every 12 or 24 h) against methicillin-resistant staphylococci Melinda K. Lacy, Pamela R. Tessier, David P. Nicolau, International Journal of Antimicrobial Agents Methicillin-resistant StaphylococciHealth SciencesAntibioticsAntimicrobial SusceptibilityPharmacology	2000	16

Page 1